Compare Danaher Corporation (DHR) vs Dolby Laboratories, Inc. (DLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs Dolby Laboratories, Inc. — how do they compare? Danaher Corporation trades at $219.87 (market cap $152.87B), while Dolby Laboratories, Inc. trades at $58.74 (market cap $5.47B). The key difference: Danaher Corporation is far larger — about 27.9× Dolby Laboratories, Inc.'s market cap, and Dolby Laboratories, Inc. pays the higher dividend (2.46%). Which is the better fit depends on your goals — on Pluang, investors hold Danaher Corporation for 69 Days and Dolby Laboratories, Inc. for 98 Days on average.
| DHR | DLB | |
|---|---|---|
Market Cap | $152.87B | $5.47B |
Volume | 5,228,698 | 1,058,284 |
Sector | Health | Technology |
52-Week High | $242.05 | $70.09 |
52-Week Low | $161.91 | $48.51 |
Typical Hold Time | 69 Days | 98 Days |
Enterprise Value | $175.08B | $4.85B |
Dividend Yield | 0.74% | 2.46% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $218.49, up 1.36% on the day, with a bullish technical signal and consistent earnings beats in recent quarters. The stock shows strong profitability with a 58.51% gross margin and 15.95% net income margin, though revenue growth has been modest. Analyst consensus is strongly bullish with a $230.31 price target, supported by institutional buying activity and a recent dividend announcement.
The outlook for DHR is positive, driven by earnings momentum and institutional confidence, but risks include elevated valuation multiples and competitive pressures in the healthcare sector. Investors should weigh the strong analyst support against potential margin compression and macroeconomic headwinds affecting capital spending.
DLB trades at $58.74, up 0.67% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong earnings beats in recent quarters, with Q3 2026 results pending. Revenue has been stable around $1.3B, with a net income margin of 18.9% in 2025. Recent news highlights expansion of Dolby Atmos and Vision with Meta and a leadership transition to Marc Whitten.
The outlook is mixed, with a consensus analyst price target of $90.33 suggesting significant upside, but technical indicators and a projected net cash flow decline in 2026 pose risks. Investment opportunities lie in the company's high gross margins and strategic partnerships, while risks include execution challenges and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About Dolby Laboratories, Inc.
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
Read more on DLB →
